fasudil has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies
fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.
Squamous Cell Carcinoma of Head and Neck: The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this cancer.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyamoto, C | 1 |
| Maehata, Y | 1 |
| Motohashi, K | 1 |
| Ozawa, S | 1 |
| Ikoma, T | 1 |
| Hidaka, K | 1 |
| Wada-Takahashi, S | 1 |
| Takahashi, SS | 1 |
| Yoshino, F | 1 |
| Yoshida, A | 1 |
| Kubota, E | 1 |
| Hata, R | 1 |
| Lee, MC | 1 |
1 other study available for fasudil and Squamous Cell Carcinoma of Head and Neck
| Article | Year |
|---|---|
Fasudil, a Rho kinase inhibitor, suppresses tumor growth by inducing CXCL14/BRAK in head and neck squamous cell carcinoma.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; | 2014 |